1-(3-methoxyphenyl)propane-1,3-diol | 51699-44-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-(3-methoxyphenyl)propane-1,3-diol
• 英文别名: 1-(m-Methoxyphenyl)-propandiol-1,3
• CAS: 51699-44-6
• 化学式: C₁₀H₁₄O₃
• 分子量: 182.219
• InChiKey: CSQLZSYIVJXCRZ-UHFFFAOYSA-N

物化性质

• 沸点：
  350.5±32.0 °C(Predicted)
• 密度：
  1.149±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  49.7
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2909499000

反应信息

• 作为反应物：
  描述：

  1-(3-methoxyphenyl)propane-1,3-diol 在 4-二甲氨基吡啶 、 potassium carbonate 、 三乙胺 作用下， 以 二氯甲烷 、 丙酮 、 乙腈 为溶剂， 反应 65.25h， 生成 1-(3-methoxyphenyl)-3-(4,5,6,7-tetrabromo-2H-benzotriazol-2-yl)propan-1-ol
  参考文献：
  名称：

  Synthesis of novel chiral TBBt derivatives with hydroxyl moiety. Studies on inhibition of human protein kinase CK2α and cytotoxicity properties

  摘要：

  The efficient method for the synthesis of novel 4,5,6,7-tetrabromo-1H-benzotriazole (TBBt) derivatives bearing a single stereogenic center has been developed. New compounds with a variety of substituents at the meta- and para-position of the phenyl ring are reported. All of the presented compounds were obtained using classical synthetic methods, such as bromination of benzotriazole, and its subsequent alkylation by monotosylated arylpropane-1,3-diols, which in turn have been synthesized through reduction of the corresponding prochiral β-keto esters, and the selective monotosylation of the primary hydroxyl group. The influence of the new and previously reported N-hydroxyalkyl TBBt derivatives on the activity of human protein kinase CK2α catalytic subunit was examined. The most active were derivatives with N-hydroxyalkyl substituents (IC50 in 0.80-7.35 μM range). A binding mode of (R)-1-(4,5,6,7-tetrabromo-2H-benzotriazol-2-yl)butan-3-ol 7b to hCK2α has been proposed based on in silico docking studies. Additionally, MTT-based cytotoxicity tests demonstrated high activities of novel 1-aryl-3-TBBt-propan-1-ol and 3-TBBt-propan-1,2-diol derivatives against human peripheral blood T lymphoblast (CCRF-CEM), and moderate anti-tumor activities against human breast adenocarcinoma (MCF7) cell lines.

  DOI：

  10.1016/j.ejmech.2014.07.019
• 作为产物：
  描述：

  ethyl 3-hydroxy-3-(3-methoxyphenyl)propanoate 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 生成 1-(3-methoxyphenyl)propane-1,3-diol
  参考文献：
  名称：

  A prodrug approach towards the development of tricyclic-based FBPase inhibitors

  摘要：

  For the purpose of reducing the strong CYP3A4 inhibitory potency of diamide prodrug 4, cyclic prodrugs of tricyclic-based FBPase inhibitors were synthesized. Extensive SAR studies led to the discovery of pyridine-containing cyclic prodrug 20, which strongly inhibited glucose production in monkey hepatocytes and also showed weak CYP3A4 inhibitory potency. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.03.017

文献信息

• 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
  申请人：Schnute Edward Mark

  公开号：US20050004161A1

  公开（公告）日：2005-01-06

  The invention provides a compound of formula I: wherein A, B, R 1 , R 2 , R 3 , and R 4 are as defined in the specification. The compounds of the present invention are useful for treating viral infections, in particular a herpesviral infection.

  该发明提供了化合物I的结构，其中A、B、R1、R2、R3和R4如规范中定义。本发明的化合物对治疗病毒感染，特别是单纯疱疹病毒感染，具有实用价值。
• [EN] LIVER-SPECIFIC AMPK AGONIST, PREPARATION METHOD THEREFOR AND USES THEREOF<br/>[FR] AGONISTE DE L'AMPK SPÉCIFIQUE AU FOIE, SON PROCÉDÉ DE PRÉPARATION ET SES APPLICATIONS<br/>[ZH] 肝脏特异性AMPK激动剂及其制法和应用
  申请人：CASCADE SHANGHAI PHARMACEUTICAL TECH CO LTD

  公开号：WO2020143800A1

  公开（公告）日：2020-07-16

  本发明提供了肝脏特异性AMPK激动剂及其制法和应用。具体地，本发明提供了一种如下式(I)所示的化合物，以及其用于治疗包含非酒精性脂肪肝(NAFL)、非酒精性脂肪肝炎(NASH)及其相关肝硬化、肝癌在内的非酒精性脂肪肝病(NAFLD)，或肥胖、糖尿病、高甘油三酯血症、高胆固醇血症、动脉粥样硬化、心血管疾病、代谢性疾病等疾病的用途。其中，各基团定义如说明书中所示。
• Studies on the chemoenzymatic synthesis of (R)- and (S)-methyl 3-aryl-3-hydroxypropionates: the influence of toluene-pretreatment of lipase preparations on enantioselective transesterifications
  作者：Paweł Borowiecki、Maria Bretner

  DOI：10.1016/j.tetasy.2013.06.004

  日期：2013.8

  Two series (para- and meta-substituted) of racemic methyl esters of 3-aryl-3-hydroxypropionic acid were prepared after which the enantiomers were separated by an enzyme-catalyzed transesterification. Several lipases were investigated as the catalyst. The influence of the enzyme pretreatment, as well as substrate concentration, reaction temperature, stirring manner, and substrate conversion on the stereochemical outcome of the biotransformation process were investigated in detail. The best results were achieved by using solvent-pretreated lipase from Pseudomonas fluorescens or Burkholderia cepacia suspended in toluene, and vinyl acetate as the acetyl group donor. (C) 2013 Elsevier Ltd. All rights reserved.
• Schaal,C., Bulletin de la Societe Chimique de France, 1973, p. 3083 - 3086
  作者：Schaal,C.

  DOI：——

  日期：——
• [EN] 4-OXO-4,7-DIHYDROTHIENO[2,3-B]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS<br/>[FR] 4-OXO-4,7-DIHYDROTHIENO[2,3-B]PYRIDINE-5-CARBOXAMIDES UTILISES COMME AGENTS ANTIVIRAUX
  申请人：PHARMACIA & UPJOHN CO LLC

  公开号：WO2005003140A1

  公开（公告）日：2005-01-13

  The invention provides a compound of Formula (I) wherein A, B, R1, R2, R3, and R4 are as defined in the specification. The compounds of the present invention are useful for treating viral infections, in particular a herpesviral infection.